81
Pro
0
Against

The drug only melts the fat deep inside the belly, not the fat you can pinch on the skin or in the arms and legs.

Scientific Claim

Tesamorelin selectively reduces visceral adipose tissue without affecting subcutaneous abdominal or limb fat in HIV-infected adults on antiretroviral therapy with abdominal fat accumulation, indicating tissue-specific action.

Original Statement

Trunk fat (P < 0.001), waist circumference (P = 0.02), and waist-hip-ratio (P = 0.001) improved, with no change in limb or abdominal SC fat.

From study:Unknown Title

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The study used precise body composition measurements and demonstrated selective effect with statistical significance, justifying definitive causal language.

Evidence from Studies

Supporting (1)

81
81

Unknown Title

Randomized Controlled Trial
Human

Tesamorelin helped HIV patients lose belly fat deep inside their abdomen without shrinking fat in their arms, legs, or just under the skin, showing it targets only the bad belly fat.

Contradicting (0)

0
No contradicting evidence found